82 related articles for article (PubMed ID: 20635245)
1. HIV antiviral drug resistance: patient comprehension.
Racey CS; Zhang W; Brandson EK; Fernandes KA; Tzemis D; Harrigan PR; Montaner JS; Barrios R; Toy J; Hogg RS
AIDS Care; 2010 Jul; 22(7):816-26. PubMed ID: 20635245
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
5. Outpatient pharmacy care and HIV viral load response among patients on HAART.
Castillo E; Palepu A; Beardsell A; Akagi L; Yip B; Montaner JS; Hogg RS
AIDS Care; 2004 May; 16(4):446-57. PubMed ID: 15203413
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
7. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
[TBL] [Abstract][Full Text] [Related]
8. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
9. "The way I see it": the effect of stigma and depression on self-perceived body image among HIV-positive individuals on treatment in British Columbia, Canada.
Palmer AK; Duncan KC; Ayalew B; Zhang W; Tzemis D; Lima V; Montaner JS; Hogg RS
AIDS Care; 2011 Nov; 23(11):1456-66. PubMed ID: 21767109
[TBL] [Abstract][Full Text] [Related]
10. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
Cruess DG; Minor S; Antoni MH; Millon T
J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
[TBL] [Abstract][Full Text] [Related]
11. Determinants of hospital admission among HIV-positive people in British Columbia.
Weber AE; Yip B; O'Shaughnessy MV; Montaner JS; Hogg RS
CMAJ; 2000 Mar; 162(6):783-6. PubMed ID: 10750463
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of food insecurity among HIV-infected individuals receiving HAART in a resource-rich setting.
Anema A; Weiser SD; Fernandes KA; Ding E; Brandson EK; Palmer A; Montaner JS; Hogg RS
AIDS Care; 2011 Feb; 23(2):221-30. PubMed ID: 21259135
[TBL] [Abstract][Full Text] [Related]
13. Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy.
Moore DM; Hogg RS; Yip B; Wood E; Harris M; Montaner JS
HIV Med; 2006 Jul; 7(5):311-6. PubMed ID: 16945076
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
[TBL] [Abstract][Full Text] [Related]
15. The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.
Castor D; Vlahov D; Hoover DR; Berkman A; Wu YF; Zeller B; Brechtl J; Hammer SM
J Med Virol; 2009 Aug; 81(8):1323-35. PubMed ID: 19551816
[TBL] [Abstract][Full Text] [Related]
16. Mortality is influenced by locality in a major HIV/AIDS epidemic.
Druyts EF; Rachlis BS; Lima VD; Harvard SS; Zhang W; Brandson EK; Strathdee SA; Montaner JS; Hogg RS
HIV Med; 2009 May; 10(5):274-81. PubMed ID: 19210694
[TBL] [Abstract][Full Text] [Related]
17. HIV-related knowledge and adherence to HAART.
Weiss L; French T; Finkelstein R; Waters M; Mukherjee R; Agins B
AIDS Care; 2003 Oct; 15(5):673-9. PubMed ID: 12959818
[TBL] [Abstract][Full Text] [Related]
18. Telephone nurse counseling improves HIV medication adherence: an effectiveness study.
Cook PF; McCabe MM; Emiliozzi S; Pointer L
J Assoc Nurses AIDS Care; 2009; 20(4):316-25. PubMed ID: 19576548
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada.
O'Neil CR; Palmer AK; Coulter S; O'Brien N; Shen A; Zhang W; Montaner JS; Hogg RS
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):134-41. PubMed ID: 22318879
[TBL] [Abstract][Full Text] [Related]
20. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
Zorrilla CD; Santiago LE; Knubson D; Liberatore K; Estronza G; Colón O; Acevedo M
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
